# Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant

> **NCT00970073** · NA · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 30 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **BIOLOGICAL:** Thymoglobulin 3mg total
- **BIOLOGICAL:** Thymoglobulin 4.5mg total
- **DRUG:** Mycophenolate mofetil
- **DRUG:** tacrolimus 3-8
- **DRUG:** tacrolimus 8-12

## Key facts

- **NCT ID:** NCT00970073
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2015-06-15
- **Final completion:** 2015-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00970073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00970073, "Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00970073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*